pallavi's blog

Radial Artery Compression Devices Market: Introduction

According to the report, the global radial artery compression devices market was valued at US$ 108.6 Mn in 2018 and is projected to expand at a CAGR of ~8% from 2019 to 2027. Radial compression devices are compulsorily used after every angiography and angioplasty procedures. Increase in radial approach for percutaneous coronary intervention procedures is likely to be responsible for rise in demand for radial compression devices. Rise in prevalence of coronary heart disease, preference for radial access in percutaneous coronary intervention (PCI) procedures worldwide, and a large number of training initiatives by cath labs are the major factors anticipated to drive the global radial artery compression devices market during the forecast period. North America held a major share of the global radial artery compression devices market in 2018, due to high prevalence and increase in incidence of cardiovascular disease in the U.S. and Canada and wide base of medical device companies in the U.S.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=73941

The radial artery compression devices market in Asia Pacific is expected to expand at a high CAGR of 8.8% from 2019 to 2027. Transformation in the healthcare scenario in Asia Pacific is encouraging healthcare professionals to opt for transradial artery access for coronary angiography and percutaneous coronary intervention (PCI). Thus, adoption of radial artery compression devices for gaining hemostasis is expected to propel the market in Asia Pacific in the near future.

 Request for Analysis of COVID19 Impact on Radial Artery Compression Devices Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=73941

Launch of Radial Artery Compression Devices to Drive Market

Rise in prevalence of cardiovascular disorders across the world has fueled the demand for radial artery compression devices. According to the American Heart Association estimates, more than 130 million adults are likely to suffer from cardiovascular disorders in the U.S. by 2035. Increase in efforts by independent cath labs for the staff training is ensuring the increased presence of skilled professionals. This, in turn, would increase the use of the radial artery compression devices and favor the market growth. For instance, in 2009, Jesse Brown VA Medical Center in Chicago had taken initiative to promote staff education outside the cath lab on adoption of radial artery compression devices.

Companies operating in the radial artery compression devices market plan to manufacture more improved radial compression devices, which can achieve hemostasis without compromising local nerve structure. Improvement in material design is expected to fuel adoption of these devices. Thus, launch of products with design enhancement is expected to fuel sales of radial artery compression devices. For instance, in August 2019, Merit Medical Systems, Inc. launched PreludeSYNC EVO radial compression device in the market in the U.S. In February 2019, Merit Medical Systems, Inc. announced the availability of PreludeSYNC DISTAL Compression Device in the U.S., Europe, Africa, the Middle East, and Asia Pacific

Buy Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=73941&ltype=S

Growth Strategies of Key Players

Key players operating in the global radial artery compression devices market include Medtronic plc, Abbott Laboratories, Terumo Corporation, Teleflex Incorporated, Merit Medical Systems, Inc. Forge Medical, Inc., Semler Technologies, Inc. dba Advanced Vascular Dynamics, Medplus, Inc., and TZ Medical, Inc. These companies engage in research & development activities to develop novel products in order to expand product offerings and customer base. In October 2017, Medtronic plc. established an innovation center in Chengdu, Singapore. In July 2018, the U.S. FDA gave the marketing approval for TZ Medical, Inc.’s patented product, Adjustable Radial Cuff (ARC) Hemostasis Device, in the U.S.

Read More Information:

https://www.transparencymarketresearch.com/radial-artery-compression-devices-market.html

Browse more Market Reports:

Peptide Therapeutics Market:

https://www.transparencymarketresearch.com/peptide-therapeutics-market.html

Implantable Medical Devices Market:

https://www.transparencymarketresearch.com/global-implantable-medical-devices-market.html

Compression Therapy Market:

https://www.transparencymarketresearch.com/compression-therapy-market.html

About Us:

Transparency Market Researchis a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: 
https://www.transparencymarketresearch.com/

 

 

 

The motion sickness treatment market has evolved steadily over the years driven by expanding scope of pharmacologic therapy. Growing array of medications used in pharmacotherapy to alleviate the symptoms of motion sickness has underlined the lucrativeness quotient for both over-the-counter (OTC) drug makers and prescription drug producers. Particularly, the conspicuous presence of OTC drug manufacturers in developed as well as emerging markets has resulted in a highly fragmented landscape. This has changed the dynamic of competition among the ecosystem of OTC and prescription drug makers in the motion sickness treatment market, notes Transparency Market Research (TMR).

Over the past few years, clinicians and the healthcare industries have gained better understanding of the pathophysiology of motion sickness, thereby helping share the varied contours of the motion sickness treatment market. A growing body of clinical studies that evaluate recent drug interventions on the underlying symptoms have been instrumental in broadening the scope of treatments, world over. A range of drug therapies have hit the motion sickness treatment market; however, the adverse side effects are crucial for the medical and patient communities.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39320

New Generation of Drugs Aim at Reducing Side-Effects

A fast emerging category is anticholinergics, particularly scopolamine, in the motion sickness treatment market. The uptake of anticholinergics in the form of transdermal scopolamine patches has been gathering traction in the market. The anticholinergics segment is expected to hold at least half of the share of the global market during the assessment period. Of note, research and development activities pertaining to the commercialization of intranasal scopolamine are likely to change the future course of the market substantially.

On the other hand, second-generation antihistamines are gathering steam as OTC drug for alleviating or substantially ameliorating the symptoms of motion sickness such as vertigo, nausea, and vomiting. They are being considered clinically better than first-generation ones due to their ability to work via peripheral versus central receptors. However, an assortment of first generation antihistamines are available over the counter and a few have been approved by the FDA for indications in children and adults.

Request customization on Motion Sickness Treatment Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=39320

Still, pediatric remains a challenging category for drug manufacturers tapping into the prevailing opportunities in the market. Further, a range of components with possible antihistaminergic effect have been intensively studied, expanding the avenues for growth of the motion sickness treatment market.

Understanding Use of Symptom Inducing Tech to Drive Future Research in Emerging Markets

Asia Pacific among all regions is emerging as a market with immense potential. The regional market is anticipated to gain shares substantially with the strides the global motion sickness treatment market in the next five years span. Growing penetration of prescription motion sickness drugs among a fast growing numbers of travelers has been fueling its growth. Developed markets, particularly North America, have prospered on the back of large uptake of high-cost prescription drugs. On the other hand, the advent of generic transdermal scopolamine patches will shape the revenue generation of various key regions in the motion sickness treatment market.

Buy Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=39320&ltype=S

Rapidly rising use of information technology and virtual reality representations and modern simulation systems that induce motion sickness have considerably shaped our understanding of the etiology of the disease. Tellingly, this will help researchers test new drug intervention approaches. A case in point is neuropharmacological investigations gathering steam among the research community.

Read More Information:

https://www.transparencymarketresearch.com/pressrelease/motion-sickness-treatment-market.htm

Browse more Market Reports:

Life Sciences Tools Market:

https://www.transparencymarketresearch.com/life-sciences-tools.html

Analgesics Market:

https://www.transparencymarketresearch.com/analgesics-market.html

Respiratory Pathogen Testing Market:

https://www.transparencymarketresearch.com/respiratory-pathogen-testing-market.html

About Us:

Transparency Market Researchis a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: 
https://www.transparencymarketresearch.com/

 

 

Global Alternative Healthcare Providers Market: Overview

Practice of complementary and alternative medicine comprises many different areas of medicines. In addition to that, it is possible that many parts of one field will overlap with another in another area. A case in point is acupuncture, which finds use in both alternative and conventional medicine. Alternative medicine refers to those medical treatments that find utilization instead of conventional therapies. Few people call them complimentary or integrative medicine. Many people make use of alternative therapies so as to make them deal and feel better with diseases like cancer. In this type of treatment, how one feels is an important part in how you cope up with the disease.

Many of the alternative healthcare therapies focus on the reduction of and relaxation from stress. These therapies increase general sense of wellbeing, relieve anxiety, and calm one’s emotions. Several doctors, researchers, and nurses have exhibited interest in the concept of positive emotions making improvements in one’s health. These factors are estimated to propel the global alternative healthcare providers market toward growth over the forecast tenure.

This report on the global alternative healthcare providers market takes a closer look at the key changes in consumer preferences and those preferences affect the growth of market. The insights offered into the report assist investors and the market players in making an informed choice about the market. The information shared in the report will help the stakeholders formulate strategies accordingly

 Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6017

Growing Faith and Awareness in Alternative Medicines Escalates Demand

The global alternative healthcare providers market has prospered on the back of the growing interest of people in such forms of medicines. Growing preference for alternative medicines has resulted from people’s increasing willingness to experiment with alternative medicines.

Alternative healthcare providers make an offering of a wide variety of products and practices and medical and healthcare systems that are used by patients sans medical supervision. Usually, alternative medicines and treatments are not availed by the people suffering from various chronic diseases like diabetes, cancer, liver disease, and osteoporosis. However, there has been a slight change in attitude, a few patients suffering from such chronic diseases are opting for alternative medicines. Such changes in the behavior pattern of patients are expected to spearhead the expansion of the global alternative healthcare providers market in years to come.

Yoga, ayurveda, homeopathic medicines, acupuncture, and unani medicines are some of the types of alternative medicines. The global alternative healthcare providers market is likely to be driven by growing adoption and use of various natural wellness and supplements medicine. In addition to that favorable government initiatives in certain countries, particularly in the Asia Pacific, is expected to create substantial opportunities of growth for the global alternative healthcare providers market over the period of review.

 Request for Analysis of COVID19 Impact on Alternative Healthcare Providers Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=6017

Global Alternative Healthcare Providers Market: Regional Outlook

Key geographies mentioned in the global alternative healthcare providers market are North America, Europe, Latin America, the Middle East and Africa, and Asia Pacific. Of these regions, North America is estimated to account for the leading share of the global alternative healthcare providers market over the tenure of forecast. The regional dominance of the region lies in the growing awareness and belief in alternative medicines across the region. In addition, increased prevalence of various chronic disorders such as cancer, hypertension, and diabetes are likely to emerge as significant growth factors for the alternative healthcare providers market in North America.

On the other hand, Asia Pacific is likely to emerge as a rapidly growing market over the assessment timeframe. Many alternative medicines such as yoga, acupuncture, and ayurveda had its origin in the region of Asia Pacific. Boom in the tourism in Asia Pacific is marked with many opting for yoga, ayurvedic, and acupuncture sessions in Asia Pacific. Growth in tourism is estimated to positively influence the alternative healthcare providers market in Asia Pacific.

 Pre book Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=6017&ltype=S

Global Alternative Healthcare Providers Market: Companies Mentioned in Report

Key players profiled in the global alternative healthcare providers market are The Healing Company, Columbia Nutritional Inc., Pure encapsulations, Inc., John Schumacher’s Unity Woods Yoga Center, Pure encapsulations, Inc., and Allen Laboratories Ltd.

Browse more Market Reports:

Assistive Listening Devices Market:

https://www.transparencymarketresearch.com/assistive-listening-devices-market.html

Portable Oxygen Concentrators Market:

https://www.transparencymarketresearch.com/portable-oxygen-concentrators.html

Aromatherapy Market:

https://www.transparencymarketresearch.com/aromatherapy-market.html

About Us:

Transparency Market Researchis a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: 
https://www.transparencymarketresearch.com/

 

 

The global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market was valued at approximately US$ 2.9 Bn in 2016 is projected to register cumulative annual growth rate (CAGR) of over 3.2% from 2017 to 2025, according to a new report published by Transparency Market Research titled “Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. The report suggests that rising incidence of the development of antibiotic resistant strains among all age groups are likely to spur the demand of MRSA Drugs in the coming years (2017 to 2025). As key players introduce novel anti-MRSA agents in developed markets such a North America and Europe, these regions are likely to account for dominating share of the global MRSA Drugs market. Established presence & wide distribution networks of major players and growing market penetration of emerging players are likely to boost growth of Asia Pacific MRSA Drugs market at a CAGR of around 3.7% from 2017 to 2025.

 Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1315

Development of Treatment-Emergent Resistance in MRSA-Infected Patients to Restrain the Growth of MRSA Drugs

According to CDC, around 33% of the people carry staphylococcus aureus, also known as staph, in their nose. But over the decades, few strains of staph such as MRSA (Methicillin-resistant Staphylococcus Aureus) have become resistant to some antibiotics that once destroyed it. MRSA strains are thus a type of staph that are resistant to beta-lactam antibiotic called methicillin. Around 1% of the population carrying staphylococcus aureus on their nose or skin are infected by MRSA. However, increased practice of prescribing antibiotics, 50% of which are unnecessary and inappropriate, is responsible to give rise to treatment-emergent resistance in MRSA-infected patients. According to the CDC, resistance to tigecycline and vancomycin, which are the effective and potent therapeutic options for severe MRSA infection, has emerged. Such treatment-emergent resistant strains developing in the MRSA-infected patients are expected to restrain the growth of MRSA drugs market during the forecast period.

 Request for Analysis of COVID-19 Impact on Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1315

Lipopeptide drug class to lose the market share

The report offers detailed segmentation of global MRSA drugs market on the basis of drug class, route of administration, and distribution channel. Among the drug class, lipopeptide is poised to account for leading share of the global market during the forecast period from 2017 to 2025. However, the segment is expected to lose its market share from 31.6% in 2016 to 30.5% by the end of 2025, owing to the loss of patent exclusivity for daptomycin in 2016, and emergence of generic drug molecules in lipopeptide drug class. Key pharmaceuticals companies such as Pfizer, Inc. involved in the manufacturing of oxazolidinones against MRSA infection, and their strong positioning in the global MRSA drugs market is likely to get boost the growth of oxazolidinone segment during the forecast period.

Oral to Be the Most Promising Route of Administration to Invest In

Various route of administration offered in the report are oral and parenteral. Parenteral route of administration accounted for highest market share of 72.2% in 2016, due to the increased investment in the pharmaceutical sector by key antibiotics manufacturers to boost the production of intravenous anti-MRSA antibiotics. Oral route of administration is expected to get a boost in terms of revenue by 2025, which is attributable to the key companies involved in the R&D of anti-MRSA vaccines.

 Buy Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=1315&ltype=S

Asia Pacific to Register Exponential Growth Rate and Offer Huge Incremental Opportunity

Geographically, the global MRSA drugs market is segmented into five major regions, which are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2016, North America accounted for the highest market share in terms of revenue, which is attributable to the investments by U.S. based key players in the R&D of screening tools for MRSA infection. Europe is the second most prominent region in the global MRSA drugs market, which is projected to grow during the forecast period, due to research grants by the public & private players in the European countries to propel the R&D of anti-MRSA antibiotics. However, huge patient pool in the countries of China and India, and uncontrolled consumption of antibiotics in India are estimated to fuel the growth of MRSA drugs market in Asia Pacific with relatively significant CAGR of 3.7% during 2017-2025.

Ask For Discount:

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1315

Key Players such as Merck & Co., Inc., and Pfizer, Inc. are Likely to Continue to Lead the Global MRSA Drugs Market

The prominent players operating in the global MRSA Drugs Market are Basilea Pharmaceutica Ltd., The Medicines Company, Theravance Biopharma, Allergan, Merck & Co., Inc., and Pfizer, Inc. Investing in the R&D and clinical trials of unique drug molecules in topical dosage form is the major strategy being adopted by key manufacturers to stay ahead in the rising competition.

Browse more Market Reports:

Assistive Listening Devices Market:

https://www.transparencymarketresearch.com/assistive-listening-devices-market.html

Portable Oxygen Concentrators Market:

https://www.transparencymarketresearch.com/portable-oxygen-concentrators.html

Aromatherapy Market:

https://www.transparencymarketresearch.com/aromatherapy-market.html

About Us:

Transparency Market Researchis a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: 
https://www.transparencymarketresearch.com/

 

 

Transparency Market Research (TMR) has published a new report on the life science reagents market for the forecast period of 2019–2027. According to the report, the global life science reagents market was valued at around US$ 37,000 Mn in 2018, and is projected to expand at a CAGR of nearly 8% from 2019 to 2027.

Life Science Reagents Market: Overview

  • Life science reagents play a critical role in the manufacturing and testing of pharmaceutical products, cell-based products, and several other healthcare-related solutions. The growth of the global life science reagents market is attributed to the increase in the global geriatric population, which is more prone to different types of infectious diseases. Moreover, the increase in the incidences of infectious diseases and technical advancements in the life science industry are boosting the growth of the global life science reagents market.
  • North America dominated the global life science reagents market in 2018, and this trend is expected to continue during the forecast period too. This is attributed to the increase in research and development activities in the region, which drive the demand for life science reagents to perform various research activities.
  • However, the increase in the number of local manufacturers creating pricing pressure in the market is likely to hamper the growth of the global life science reagents market in North America during the latter half of the forecast period. Asia Pacific is expected to be a highly lucrative market for life science reagents during the forecast period.

 Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1162

Technological Advancements and High Prevalence of Chronic and Infectious Diseases to Drive Market Growth

  • Technological advancements in the field of life sciences and biotechnology have resulted in numerous changes in healthcare diagnostics, drug discovery, personalized medicines, forensic sciences, and clinical research & development, majorly driving the growth of the life science reagents market.
  • Developments in enzyme-linked immune assay technology (ELISA), polymerase chain reaction (PCR) such as digital PCR, rtPCR, chromatography, single cell technology, next-generation sequencing (NGS), and flow cytometry techniques, and their applications in the healthcare industry such as disease diagnostics and treatment monitoring are propelling the growth of the global life science reagents market.
  • Additionally, the diagnosis of infectious and chronic diseases is one of the leading applications of in-vitro diagnostics. Life science reagents (both, biological and chemical reagents) are integral and vital parts of the any diagnostic test.
  • The outbreak of infectious viruses such as Zika, in 2015, positively impacted the in-vitro diagnostic industry. This, in turn, increased the demand for life science reagents.

 Request for Analysis of COVID19 Impact on Life Science Reagents Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1162

Life Science Reagents Market: Immunoassay Reagents Segment to Remain Prominent

In terms of product, the global life science reagents market has been classified into chromatography reagents, molecular diagnostic reagents, immunoassay reagents, clinical chemistry reagents, flow cytometry reagents, cell & tissue culture reagents, hematology & hemostasis reagents, microbiology reagents, and others. The immunoassay reagents segment dominated the global life science reagents market in 2018 and the trend is likely to continue during the forecast period. 

Life Science Reagents Market: Hospitals & Diagnostic Laboratories to be a Promising Segment

  • In terms of end user, the global life science reagents market has been divided into hospitals & diagnostic laboratories, commercial & contract research manufacturers, academic & research institutes, and others (blood banks, forensic laboratories, and government institutes).
  • The hospitals & diagnostic laboratories segment is expected to be a highly lucrative segment of the global life science reagents market during the forecast period. The segment is likely to be driven by an increase in the number of diagnostic tests.

 Buy Life Science Reagents Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=1162&ltype=S

Life Science Reagents Market: Competitive Landscape

  • Hoffmann-La Roche AG and Thermo Fisher Scientific, Inc. lead the global life science reagents market.
  • The global life science reagents market is fragmented in terms of number of players. Key players in the global market include Hoffmann-La Roche AG, Danaher Corporation, Abbott, Siemens Healthineers, DiaSorin S.p.A, Sysmex Corporation, bioMerieux SA, Thermo Fisher Scientific, Inc., BD, Merck KGaA, Agilent Technologies, Inc., and Waters Corporation. Wide distribution network, new product development, and mergers & acquisitions are the key strategies followed by these major players to operate their businesses in the global life science reagents market. 

Browse more Market Reports:

Ophthalmic Knives Market:

https://www.transparencymarketresearch.com/ophthalmic-knives-market.html

Canes and Crutches Market:

https://www.transparencymarketresearch.com/canes-crutches-market.html

Sirolimus Market:

https://www.transparencymarketresearch.com/sirolimus-market.html

About Us:

Transparency Market Researchis a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: 
https://www.transparencymarketresearch.com/

 

 

According to Transparency Market Research’s latest report on the global collagen peptide and gelatin market for the historical period 20172018 and forecast period 20192027, increase in commercialization of novel collagen-based drug delivery systems and rise in social awareness about personal well-being are projected to drive the global collagen peptide and gelatin market. According to the report, the global collagen peptide and gelatin market was valued at US$ 5,976.9 Mn in 2018 and is projected to expand at a CAGR of 8.7% from 2019 to 2027.

Mergers and Acquisitions are Key Ploy to Maintain Strong Market Hold

Major factors driving the collagen peptide application in nutraceuticals sector are awareness, affordability, and accessibility. People are more concerned about health and lifestyle, which has increased the demand for dietary supplements. In case of personal well-being, people are opting for functional foods and nutraceuticals to prevent age-related diseases and improve their health. Nutraceuticals are used by geriatric population and sportspersons, as these are a rich source of proteins and other essential supplements. Thus, deficiencies due to nutrition are not related to the economic classes, but to the type of food consumed by the people.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1070

In addition, mergers & acquisitions, new prebiotic/probiotic product launches, and heart health-enhancing nutraceuticals are expected to augment market growth. Use of collagen in several medical devices and drugs is increasing, owing to its characteristics such as biodegradability, high absorption rates, positive effect on wound healing, and easy availability. Use of collagen in wound healing application is on the rise due to increase in geriatric and obese population worldwide along with rise in prevalence of several chronic diseases such as diabetes. It also reduces the occurrence of infections at the wound sites and minimizes the irritation. The use of collagen-based wound healing products is gaining utmost importance and this is likely to drive the market.

Enquire before buying Collagen Peptide and Gelatin Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1070

Based on type, the global collagen peptide and gelatin market has been divided into Type I, type II and others. Based on source, type I is further sub segmented into fish and others. Fish is further bifurcated into tilapia, carp, and others. Type II is segmented into hydrolyzed and undenatured. The type I collagen held major share in the global collagen peptide and gelatin market in 2018 and is estimated to expand at the highest CAGR during the forecast period. Increasing consciousness among people towards personal care and health has led to the rise in the use of nutraceuticals and cosmeceuticals. High demand for these products has led to the overall rise in the global collagen peptide and gelatin market as collagen is the main ingredient for these products owing to its anti-aging properties etc.

Buy Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=1070&ltype=S

North America Market Expected to Continue Leading in Coming Years

Geographically, the global collagen peptide and gelatin market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global collagen peptide and gelatin market in 2018, followed by Europe. North America accounted for major share of the global collagen peptide and gelatin market in 2018, owing to increasing R&D activities will result in development of novel drug formulations.

The collagen peptide and gelatin market in Asia Pacific is likely to expand at a higher CAGR from 2019 to 2027. Increasing geriatric population creates demand for collagen based bone substitutes, nutritional products, and other drug delivery systems.

GELITA AG, Catalent, Inc., Rousselot, Nitta Gelatin, Inc., Capsugel Belgium NV, Amicogen, Inc. are the leading players in the global collagen peptide and gelatin market that hold majority of the market share The global collagen peptide and gelatin market is fragmented in terms of number of players. Key players in the global market include Amicogen, Inc, BioCell Technology LLC, Capsugel Belgium NV, Catalent, Inc., ChinaTech Peptide Co., Ltd., GELITA AG, InterHealth Nutraceuticals, Inc, Nitta Gelatin, Inc., Norland Products, Inc., Rousselot.

Browse more Market Reports:

Kidney Dialysis Equipment Market:

https://www.transparencymarketresearch.com/kidney-dialysis-equipment-market.html

Polypill Products Market:

https://www.transparencymarketresearch.com/polypill-products-market.html

Smart Insulin Pens Market:

https://www.transparencymarketresearch.com/smart-insulin-pens-market.html

About Us:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Global Dental Lights Market: Overview 

The global dental lights market is expected to increase growth in the years to come with introduction and rising popularity of environment friendly Light Emitting Diode (LED) Lights. Previously halogen lights were being used in the dental lights market. LED Lights are energy efficient and consume up to almost 70 percent less energy than their halogen counterparts. Adding to that, LED lights have longer life than halogen lights and is cost efficient as well. These factors may contribute to the rise of LED lights in the dental lights market during the forecast period 2018 to 2026. 

The global dental lights market could be divided according to Product type, End User, and Technology. By product type, the market is segmented into LED lights and Halogen lights. On the basis of End user, the global dental lights market is classified into Hospital market and dental clinic market. Based on Technology, the market is categorized into Fixed and Mobile. During the forecast period, fixed dental lights is anticipated to be leading the market on the basis of Technology. Whereas in terms of end user, the dental clinics sub-division is expected to bring larger revenue growth in the market. Adding to the progress of the global dental lights market by product type, LED lights sub-segment is presumed to be the largest. 

The report presented here is a complete evaluation of global dental lights market with large focus on market dynamics that includes market drivers, restraints, and trends and opportunities. It also offers geographical and other segmentation studies of the market. 

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=49965

Global Dental Lights Market: Trends and Opportunities 

One of the most lucrative opportunities in dental lights market could be created with the growing use of LED lights. With the help of LED lights, one does not have to adjust hotspots as it was done previously for halogen lights. LED lights remain consistent throughout their usage period. 

However, in developing countries where proper healthcare is not available, people are unaware about the technological advancements and product modification to ease the lives of consumers. Due to this lack of awareness with regard to dental lights being used in developing countries, the market may face challenge in the years to come. 

Despite lack of awareness, Led lights also remain cool during operation thus possessing no risk of burn or uncomfortable heat for the patients. LED lights have longer life span. Not only that, the total cost of ownership is also reduced, thus adding another advantage to the demand of dental lights in the global dental lights market. 

 Request for Analysis of COVID19 Impact on Dental Lights Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=49965

Global Dental Lights Market: Regional Analysis 

The global dental light marketing could be classified into the regions of Europe, Latin America, North America, Middle East and Africa, and Asia Pacific. Among these, the region that is anticipated to secure a majority of market revenue is North America. On the other hand, Asia Pacific is presumed to record a faster growth rate due to growing dental and healthcare infrastructure from developing countries of China, Japan and India. 

Pre Book Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=49965&ltype=S

Global Dental Lights Market: Companies Mentioned

 

Leading companies operating in the global dental lights market are A-dec (Austin Dental Equipment Company), Flight Dental Systems, Danaher Corporation, Midmark Corp, and TPC Advanced Technology. 

 

Read More Information:

https://www.transparencymarketresearch.com/dental-lights-market.html

 

Browse more Market Reports:

Intra-Abdominal Pressure Measurement Devices Market:

https://www.transparencymarketresearch.com/intraabdominal-pressure-measurement-devices-ipmd-market.html

Cancer Supportive Care Products Market:

http://www.transparencymarketresearch.com/cancer-supportive-care-products-market.html

Infection Prevention Devices Market:

https://www.transparencymarketresearch.com/infection-prevention-devices-market.html

About Us:

Transparency Market Researchis a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: 
https://www.transparencymarketresearch.com/

 

 

Global IV Equipment Market: Overview

The demand within the global market for IV equipment has been increasing on account of the rising incidence of chronic diseases that necessitate intravenous therapy. The field of medical sciences has been undergoing key advancements in recent times, and this has led to the induction of new healthcare devices and systems in mainstream medicine. Intravenous therapy refers to the use of infusions to deliver desired liquid medications to the veins. In common terms, intravenous infusions are known as drips and are extensively used across hospitals and healthcare centers. The need to administer timely medications to patients suffering from severe diseases has been driving demand within the global market for IV devices. Although drips are an easy way of administering the desired liquids into the body, several new IV devices have also come to the fore in recent times. Moreover, correction of electrolyte imbalances and fluid replacement therapies are also carried out with the help of IV therapy. 

 Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=49953

The global IV equipment market is segmented on the basis of product type, end-user, and region. All of these segments play a pivotal role in categorizing various growth parameters of the global IV equipment market. 

A report added by Transparency Market Research (TMR) on the global IV equipment market sheds light on several key drivers of market demand. The primary intent behind the report is to offer a scale of judgement for market growth in the forthcoming years. 

 Request for Analysis of COVID19 Impact on IV Equipment Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=49953

Global IV Equipment Market: Trends and Opportunities 

Blood transfusions have become common across the medical and healthcare industry, majorly due to the rising incidence of diseases that result in blood loss. Since intravenous therapies largely help in performing blood transfusion treatments, the demand within the global market for IV equipment is projected to reach new heights. Furthermore, patients suffering from severe diseases and disorders often struggle in oral intake of food, medication, or liquids. In such cases, IV equipment helps in administering the right doses of medication to the patients. This factor, coupled with the rising incidence of cancers, cardiovascular illnesses, and tumours, has created tremendous demand within the global market for IV equipment in recent times. 

In recent times, various types of IV equipment with enhanced quality and performance have become available in the market. As these devices and equipments prove to be effective in carrying out blood transfusions and other intravenous procedures, more number of healthcare units and hospitals are projected to buy them. Despite these favourable factors for market growth, the high costs and risks associated with the use of IV equipment could hamper market growth. 

 Pre book Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=49953&ltype=S

Global IV Equipment Market: Regional Analysis 

The demand for IV equipment market has risen by leaps and bounds in North America, majorly due to the wellness of the healthcare sector in the US and Canada. Furthermore, the proficiency and skill of doctors and medical professionals in these countries has helped in easy administration of intravenous therapies. It is projected that the market for IV equipment in Asia Pacific would expand due to growth of medical tourism to countries such as China, Indonesia, and India. 

Global IV Equipment Market: Competitive Landscape 

Some of the key players in the global IV equipment market are Baxter International Inc., ICU Medical, Smiths Group, C. R. Bard, Moog Inc., and Terumo Corporation. 

 For More Information:

https://www.transparencymarketresearch.com/iv-equipment-market.html

Global IV Equipment Market: Segmentation 

By Product Type 

·         IV Catheters

·         Infusion Pumps

·         Securement Devices

·         Drip Chambers

·         Other IV Equipment

·         Stopcocks & Check Valves

·         Administration Sets

·         Needleless Connectors 

Browse More Reports by Transparency Market Research:

Psoriatic Arthritis Therapeutics Market:

https://www.prnewswire.com/news-releases/title-high-prevalence-of-the-condition-and-huge-unmet-medical-needs-to-favour-growth-of-the-psoriatic-arthritis-therapeutics-market-tmr-301238659.html

NGS Sample Preparation Market:

https://www.prnewswire.com/news-releases/profound-ramp-up-in-agricultural-production-using-ngs-technology-fosters-growth-in-global-ngs-sample-preparation-market-technology-to-benefit-animal-sciences-as-well-tmr-301242277.html

About Us:

Transparency Market Researchis a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: 
https://www.transparencymarketresearch.com/

 

 

Global Gynaecological Cancer Drugs Market: Overview 

Treatment of gynecological cancer includes the different medications, surgeries, therapies, and chemotherapy. Selection of the way of the treatment is generally based on the type and stage of cancer. There is the type of gynecological cancer such as uterine, ovarian cancer, vaginal cancer, vulvar cancer, and cervical cancer. Each one of them is unique and different from others. 

Uncontrolled growth of abnormal cells in the female reproductive organs such as cervix, ovaries, uterus, vagina, and vulva causes gynaecological cancer. There are numerous factors responsible for the occurrence of gynecological cancer such as infection due to human papillomavirus (HPV), infertility, obesity, mutations, and early start of menstruation or late start of menopause. Increasing number of women suffering from gynaecological cancer is creating the need for its effective treatments.  

The report presents several aspects which are an analysis of impact growth of the gynaecological cancer drugs market. Moreover, the macroeconomic aspects, trends, and challenges are also discussed in this research study. These market dynamics show the current scenario along with future growth and opportunities in the global gynaecological cancer drugs market. The report also comprises CAGR, market share, year-on-year growth, revenue generated in the past and the forecast on the gynaecological cancer drugs market from 2018 to 2026. 

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=49938

Global Gynaecological Cancer Drugs Market: Drivers and Restraints 

Availability of advanced cancer screenings methods leading to an increasing number of patients. Moreover, the increasing investment by government and the private sector in order to improve facilities in the hospitals and the presence of specialists and surgeons is also resulting in an increased number of patients. Additionally, increasing awareness about the availability of treatments is boosting adoption of the gynecological cancer drugs which is likely to boost the growth of gynecological cancer drugs market. 

However, the high cost of drug development, need of high initial investment, and some possible side effects of the cancer treatment are hampering the growth of the global gynecological cancer drug market. Nevertheless, advancement in the cancer drug research and the introduction of personalized medicine approach are creating lucrative opportunities for growth over the forecast period. 

 Request for Analysis of COVID19 Impact on Gynaecological Cancer Drugs Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=49938

Global Gynaecological Cancer Drugs Market: Geographical Analysis 

On the basis of region, the gynecological cancer drug market could be segmented into North America, South America, Europe, Asia Pacific, and the Middle East and Africa. Of these regions, North America is expected to dominate the global gynecological cancer drug market owing to the high prevalence of gynecological cancer and improved healthcare facilities available in the region. The region is expected to gather revenue of US$14,700 mn by the end of 2026. However, the gynaecological cancer drugs market in Europe and Asia Pacific Excluding Japan (APEJ) are expected to witness impressive growth over the forecast period. This growth is attributable to the ongoing research and development activities are fuelling a number of clinical trials and number of pipeline drugs in the region.  

Pre Book Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=49938&ltype=S

Global Gynaecological Cancer Drugs Market: Companies Mentioned 

Some of the key players operating in the gynaecological cancer drugs market are Roche Holdings AG, AstraZeneca, Sanofi, Eli Lilly & Co., and Pfizer Inc. These players are investing in the research and development activities in order to develop novel drugs for effective treatment of gynaecological cancer.

 

Read More Information:

https://www.transparencymarketresearch.com/gynaecological-cancer-drugs-market.html

 

Browse more Market Reports:

Intra-Abdominal Pressure Measurement Devices Market:

https://www.transparencymarketresearch.com/intraabdominal-pressure-measurement-devices-ipmd-market.html

Cancer Supportive Care Products Market:

http://www.transparencymarketresearch.com/cancer-supportive-care-products-market.html

Infection Prevention Devices Market:

https://www.transparencymarketresearch.com/infection-prevention-devices-market.html

About Us:

Transparency Market Researchis a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: 
https://www.transparencymarketresearch.com/

 

 

Joint fixation systems are used in orthopedic surgeries. These are broadly categorized into internal fixator systems and external fixator systems. Internal fixators help patients to carry their body’s weight by stabilizing and supporting fractured bones and movements. This system helps reduce the length of the hospital stay and decreases the risk of infections. External fixator devices, such as Schanz screws, connecting rods, and clamps, are used to stabilize and support long bone open fractures. External fixators allow the change of dressings without disturbing the fixation system. These fixators are minimally invasive and have an ergonomic design. This helps preserve tissue functions in trauma cases.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=49926

Growth in geriatric population, increase in in prevalence of osteoarthritis diseases, surge in adoption of bone-related minimally invasive surgeries, and rise in health care spending worldwide are key factors that are expected to boost the global joint fixation systems market during the forecast period. However, high cost of minimally invasive surgeries and health related issues related to pin tract infections are likely to restrain the joint fixation systems market.

The global joint fixation systems market can be segmented based on product, patient type, extremity, end-user, and region. In terms of product type, the joint fixation system can be bifurcated into internal fixation system and external. The internal fixation systems segment can be sub-segmented into plates, screws, rods, pins, and wires. The external fixation systems segment can be further classified into tubular fixators, circular fixators, and hybrid fixators. Based on patient type, the joint fixation systems market can be segregated into adult and pediatric. The adult segment is likely to hold a major share of the global joint fixation systems market. In terms of extremity, the global joint fixation devices market can be divided into ankle and foot fractures, hand and wrist fractures, shoulder and elbow fractures, hip and pelvis fractures, tibia and femur fractures, rib fractures, and others. Based on end-user, the global joint fixation devices market can be categorized into hospitals, orthopedic clinics, accident and trauma centers, ambulatory surgical centers, and others. 

 Request for Analysis of COVID19 Impact on Joint Fixation Systems Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=49926

In terms of region, the global joint fixation devices market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In terms of revenue, North America is projected to account for a major share of the global joint fixation systems market during the forecast period. The region accounts for a large share of the joint fixation systems market due to high per capita disposable income, high prevalence of the degenerative disease of bones and joints, strong brand value of major players in the region, favorable reimbursement coverage for orthopedic surgical procedures, and rise in incidence rate of trauma-related injuries among the geriatric population. The joint fixation systems market in Asia Pacific is anticipated to expand at a considerable pace during the forecast period owing to large patient base demanding affordable care, rapid urbanization in high growth potential developing countries, and improving health care infrastructure. 

Pre Book Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=49926&ltype=S

Key players operating in the global joint fixation systems market include DePuy Synthes (Johnson & Johnson Services, Inc.), Smith & Nephew plc, Globus Medical Inc., Camber Spine Technologies, Zimmer Biomet, Orthofix Holdings, Inc. SOFEMED, Integra LifeSciences Corporation, Life Spine, Inc., Parallels IP Holdings GmbH., Stryker, and Amerra Medical Communication.

 

Read More Information:

https://www.transparencymarketresearch.com/joint-fixation-systems-market.html

 

Browse more Market Reports:

Intra-Abdominal Pressure Measurement Devices Market:

https://www.transparencymarketresearch.com/intraabdominal-pressure-measurement-devices-ipmd-market.html

Cancer Supportive Care Products Market:

http://www.transparencymarketresearch.com/cancer-supportive-care-products-market.html

Infection Prevention Devices Market:

https://www.transparencymarketresearch.com/infection-prevention-devices-market.html

About Us:

Transparency Market Researchis a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: 
https://www.transparencymarketresearch.com/

 

 

Pages: 1 2 3 4 5 ... » »»